Skip to main
PACB
PACB logo

PACB Earnings Dates & Reports

PACB Most Recent Earnings

Report DateNov 5, 2025
Period EndingQ3 2025
Est. EPS-$0.15
Actual EPS-$0.12
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

PACB Earnings per Share (EPS) History

Signup for full access
Browse free

PACB Latest Earnings

The value each PACB share was expected to gain vs. the value each share gained.

PACB reported its most recent earnings on Nov 5, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.12. This exceeded analysts' expectations of -$0.15 by 20.00%, marking a Beat.

For comparison, Pacific Biosciences of California reported EPS of -$0.17 in the same quarter last year.

The company is expected to announce its next earnings report on 02/12/2026, with analysts projecting an EPS of -$0.14.

PACB Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Feb 13, 2026
-$0.14Next earnings call Feb. 12, 2026
Q3 2025Nov 5, 2025
-$0.15-$0.12-20.00%
DeckReportListen
Q2 2025Aug 7, 2025
-$0.17-$0.13-23.53%
DeckReportListen
Q1 2025May 8, 2025
-$0.19-$0.15-21.05%
DeckReportListen
Q4 2024Feb 13, 2025
-$0.21-$0.20-4.76%
DeckReportListen
View all

PACB Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Pacific Biosciences of California’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 5, 2025
Aug 7, 2025
May 8, 2025
Feb 13, 2025

PACB Earnings FAQs

PACB last reported earnings on Nov 5, 2025 for Q3 2025, posting an EPS of -$0.12, which Beat the estimate of -$0.15 by 20.00%.

For Q3 2025, PACB reported an EPS of -$0.12, exceeding analysts' estimate of -$0.15 by 20.00%.

For Q3 2025, PACB Beat expectations with an actual EPS of -$0.12 vs. an estimated EPS of -$0.15.

Following the last earnings report on Nov 5, 2025, PACB's stock price moved — from — to —.

The next PACB earnings call is scheduled for Feb. 12, 2026, where executives will discuss financial results and outlook.

Pacific Biosciences of California (PACB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.